Last reviewed · How we verify

VPI-2690B low dose

Vascular Pharmaceuticals, Inc. · Phase 2 active Small molecule

At a glance

Generic nameVPI-2690B low dose
SponsorVascular Pharmaceuticals, Inc.
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results